{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:27:56Z","timestamp":1793647676781,"version":"4.5.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s15010-026-02858-z","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:20:25Z","timestamp":1780302025000},"page":"2257-2266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meropenem response in neonatal carbapenem-resistant Klebsiella pneumoniae: a narrative review of in vitro\u2013in vivo discordance"],"prefix":"10.1007","volume":"54","author":[{"given":"Matei","family":"Mselle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickfarajaeli","family":"Daudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2858_CR1","volume-title":"Newborns: improving survival and well-being","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Newborns: improving survival and well-being. Geneva: World Health Organization; 2023."},{"issue":"7","key":"2858_CR2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/jac\/dky099","volume":"73","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Recht J, Chua A, Dance DAB, Dhorda M, Thomas NV, et al. An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000. J Antimicrob Chemother. 2018;73(7):1737\u201349. https:\/\/doi.org\/10.1093\/jac\/dky099.","journal-title":"J Antimicrob Chemother"},{"key":"2858_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41564-021-00953-6","volume":"6","author":"K Sands","year":"2021","unstructured":"Sands K, Carvalho MJ, Portal E, Thomson K, Dyer C, Akpulu C, et al. Characterization of antimicrobial-resistant gram-negative bacteria causing neonatal sepsis. Nat Microbiol. 2021;6:1332\u201344. https:\/\/doi.org\/10.1038\/s41564-021-00953-6.","journal-title":"Nat Microbiol"},{"key":"2858_CR4","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"215","author":"LK Logan","year":"2017","unstructured":"Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215:S28\u201336. https:\/\/doi.org\/10.1093\/infdis\/jiw282.","journal-title":"J Infect Dis"},{"issue":"6","key":"2858_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/mdr.2019.0312","volume":"26","author":"G Bianco","year":"2020","unstructured":"Bianco G, Boattini M, Iannaccone M, et al. Mechanisms of carbapenem resistance in Klebsiella pneumoniae. Microb Drug Resist. 2020;26(6):1\u201312. https:\/\/doi.org\/10.1089\/mdr.2019.0312.","journal-title":"Microb Drug Resist"},{"issue":"10","key":"2858_CR6","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791\u20138. https:\/\/doi.org\/10.3201\/eid1710.110655.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"2858_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jiac.2019.01.012","volume":"25","author":"Y Harada","year":"2019","unstructured":"Harada Y, Morinaga Y, Yamada K, et al. The inoculum effect on the activity of antimicrobial agents against gram-negative bacteria. J Infect Chemother. 2019;25(6):429\u201335. https:\/\/doi.org\/10.1016\/j.jiac.2019.01.012.","journal-title":"J Infect Chemother"},{"issue":"6","key":"2858_CR8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/527442","volume":"46","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Karageorgopoulos DE. Extended-spectrum \u03b2-lactamase-producing organisms and the MIC \u201cgray zone\u201d: clinical implications. Clin Infect Dis. 2008;46(6):915\u201322. https:\/\/doi.org\/10.1086\/527442.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2858_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00362-20","volume":"64","author":"K Abdelraouf","year":"2020","unstructured":"Abdelraouf K, Tam VH. In vitro\u2013in vivo discordance in antimicrobial therapy: mechanisms and clinical implications. Antimicrob Agents Chemother. 2020;64(7):e00362-20. https:\/\/doi.org\/10.1128\/AAC.00362-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2858_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac041","volume":"9","author":"YK Yoon","year":"2022","unstructured":"Yoon YK, Kim JH, Sohn JW. In vitro versus in vivo antimicrobial activity and synergy in multidrug-resistant infections. Open Forum Infect Dis. 2022;9(3):ofac041. https:\/\/doi.org\/10.1093\/ofid\/ofac041.","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"2858_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","volume":"14","author":"JA Roberts","year":"2014","unstructured":"Roberts JA, Abdul-Aziz MH, Davis JS, Dulhunty JM, Cotta MO, Myburgh J, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14(6):498\u2013509. https:\/\/doi.org\/10.1016\/S1473-3099(14)70036-2.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2858_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/clpt.2011.267","volume":"91","author":"M Cohen-Wolkowiez","year":"2012","unstructured":"Cohen-Wolkowiez M, Watt KM, Hornik CP, Smith PB, Benjamin DK Jr. Pharmacokinetics and pharmacodynamics of antibiotics in neonates: optimizing therapy. Clin Pharmacol Ther. 2012;91(2):273\u201381. https:\/\/doi.org\/10.1038\/clpt.2011.267.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2858_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2165\/11592780-000000000-00000","volume":"50","author":"I Lutsar","year":"2011","unstructured":"Lutsar I, Metsvaht T. Understanding pharmacokinetics in the neonatal population to optimise antibiotic therapy. Clin Pharmacokinet. 2011;50(10):693\u2013707. https:\/\/doi.org\/10.2165\/11592780-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"2858_CR14","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/INF.0b013e31821c2f90","volume":"30","author":"PB Smith","year":"2011","unstructured":"Smith PB, Benjamin DK Jr., et al. Safety and efficacy of meropenem in infants with suspected or complicated intra-abdominal infections. Pediatr Infect Disease J. 2011;30(10):888\u201393. https:\/\/doi.org\/10.1097\/INF.0b013e31821c2f90.","journal-title":"Pediatr Infect Disease J"},{"key":"2858_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2147\/IDR.S115466","volume":"9","author":"C Thatrimontrichai","year":"2016","unstructured":"Thatrimontrichai C, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infection in neonatal intensive care units. Infect Drug Resist. 2016;9:347\u201354. https:\/\/doi.org\/10.2147\/IDR.S115466.","journal-title":"Infect Drug Resist"},{"issue":"12","key":"2858_CR16","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/cid\/ciy375","volume":"67","author":"L Folgori","year":"2018","unstructured":"Folgori L, Bielicki J, Heath PT, Sharland M. Antimicrobial-resistant gram-negative infections in neonates: epidemiology and clinical outcomes. Clin Infect Dis. 2018;67(12):1883\u201392. https:\/\/doi.org\/10.1093\/cid\/ciy375.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2858_CR17","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"K Chiotos","year":"2019","unstructured":"Chiotos K, et al. Treatment outcomes of multidrug-resistant gram-negative infections in pediatric and neonatal populations. Clin Infect Dis. 2019;69(12):S565\u201375. https:\/\/doi.org\/10.1093\/cid\/ciz830.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2858_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cmi.2015.05.011","volume":"21","author":"M Bassetti","year":"2015","unstructured":"Bassetti M, et al. Role of combination therapy for treatment of severe gram-negative infections. Clin Microbiol Infect. 2015;21(9):789\u201398. https:\/\/doi.org\/10.1016\/j.cmi.2015.05.011.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"2858_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","volume":"8","author":"D van Duin","year":"2017","unstructured":"van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460\u20139. https:\/\/doi.org\/10.1080\/21505594.2016.1222343.","journal-title":"Virulence"},{"key":"2858_CR20","volume-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA Wells","year":"2014","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. Available at: Newcastle\u2013Ottawa Scale Manual; 2014."},{"key":"2858_CR21","volume-title":"JBI Manual for Evidence Synthesis","author":"S Moola","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. Adelaide: Joanna Briggs Institute. Available at: JBI Manual for Evidence Synthesis; 2020."},{"key":"2858_CR22","volume-title":"Critical Appraisal Tools for Use in JBI Systematic Reviews: Checklist for Case Reports and Case Series","author":"Joanna Briggs Institute","year":"2020","unstructured":"Joanna Briggs Institute. Critical Appraisal Tools for Use in JBI Systematic Reviews: Checklist for Case Reports and Case Series. Adelaide: Joanna Briggs Institute. Available at: JBI Critical Appraisal Tools; 2020."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02858-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02858-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02858-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:50:01Z","timestamp":1793645401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02858-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2858"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02858-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study involved secondary analysis of previously published data, formal ethical approval was not required. All sources were properly cited in accordance with academic standards.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}